WHO Issues Alert Over Critical Scarcity of Obesity Injections

Less than 10% of people that would benefit from obesity jabs such as Wegovy have access to them, states the World Health Organization as it releases its initial guidance on the drugs.

Considering in excess of 1,000,000,000 people worldwide currently living with obesity, it is advocating for increased and just availability to this class of drugs.

According to projections, more than two billion will be living with obesity by 2030 if no action is taken.

"Our latest guidance affirms that excess weight is a lifelong illness that can be addressed with thorough and ongoing treatment," stated WHO director-general Tedros Adhanom Ghebreyesus.

Substantial prices, limited production capacity, and logistical bottlenecks are key barriers to broad availability to the injections that can assist patients in reducing significant body mass, explains the agency.

GLP-1 Therapy Shortage

Even under the current best projected scenario, the production of these medications would only suffice for approximately 100 million people – fewer than 10% of eligible patients, as stated by the health organization.

The guideline urges nations and manufacturers to expand access, via approaches such as voluntary licensing.

The intellectual property rights on the active ingredient – the primary ingredient of the drug Wegovy – is scheduled to end in multiple nations in 2026.

The Way Obesity Jabs Work

These medications mimick a biological compound to reduce digestion speed, suppress the appetite and enhance feelings of fullness so individuals eat less.

Patients commonly start to lose weight within a few weeks of beginning the weekly injections.

Evidence suggests patients may put most of the weight back on a year later of halting the drug, when their typical hunger return.

To be above a healthy weight increases your chance for experiencing health problems, like diabetes, heart disease, brain attack, and some cancers.

Excess weight affects people in all nations and was responsible for millions of deaths worldwide in 2024, as per the WHO.

Jennifer Baldwin
Jennifer Baldwin

A tech journalist with over a decade of experience covering UK innovation and digital transformation trends.